Catastrophic rapid onset heparin-induced thrombocytopenia--victim of our own success

Acta Cardiol. 2010 Feb;65(1):93-5. doi: 10.2143/AC.65.1.2045897.

Abstract

Heparin is integral to the treatment of acute coronary syndromes, deep vein thrombosis and its prophylaxis. An undesirable result of recurrent heparin use is rapid onset heparin-induced thrombocytopenia (HIT) within hours of exposure. This catastrophic condition is frequently diagnosed too late for therapy to be effective. We describe a case of fatal rapid onset HIT, analyze current evidence to diagnose this condition and propose a way so that it can be prevented.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Anticoagulants / adverse effects*
  • Anticoagulants / therapeutic use
  • Diagnosis, Differential
  • Disease Progression
  • Fatal Outcome
  • Follow-Up Studies
  • Heparin / adverse effects*
  • Heparin / therapeutic use
  • Humans
  • Male
  • Platelet Count
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / diagnosis
  • Thromboembolism / drug therapy
  • Time Factors

Substances

  • Anticoagulants
  • Heparin